Jeff, I believe Oppenheimer raise from $29 to $31 was deliberately done to keep the PPS lower.
Both Roth and Oppenheimer were at the conference after earnings and one of them asked for guidance. Pryzbyl was reluctant to give guidance due to wanting 6 months of EE/MT sales under his belt. When pressed Przybyl said he was comfortable with an EPS for 2014 of $1.40 (4X $0.35)
How does a +40% growth in earnings translate into a 7% increase in PT. Something was deliberately fishy there.
The markets realized the numbers were bogus and have no problem going beyond the PT.
Aging population, global position on estrogen use has turned in ANI's favor and should continue to grow.
In addition, Tesneo announcement can't be too far around the corner.
News 
Market Data 
Discover 
AI
